Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Information about LCT Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

Resources

Fact Sheets

Explaining LCT's Technology
Xenotransplantation Explained
Glossary


Diabetes

Diabetes Australia
Australian Diabetes Educators Association (ADEA)
Australian Diabetes Society (ADS)
Australian Centre for Diabetes Strategies
International Diabetes Federation
International Diabetes Institute
Juvenile Diabetes Foundation Australia (JDFA)
Juvenile Diabetes Research Foundation (JDRF)


Haemophilia

World Federation of Haemophilia
Aust Haemophilia Centre Directors' Org
Haemophilia Foundation of Australia
National Hemophilia Foundation


Huntington’s Disease

Australian Huntington’s Disease Association
International Huntington Association
Huntington’s Disease Society of America
Huntington’s Disease Association (UK)
Huntington’s Disease Association (NZ)


Stroke

National Stroke Association
National Stroke Foundation
Brain Research Institute
SAFE (Stroke Awareness for Everyone)

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd